EUSA Pharma Revenue and Competitors

Hemel Hemsptead, UK

Location

$54.2M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • EUSA Pharma's estimated annual revenue is currently $45.7M per year.(i)
  • EUSA Pharma's estimated revenue per employee is $251,250
  • EUSA Pharma's total funding is $54.2M.

Employee Data

  • EUSA Pharma has 182 Employees.(i)
  • EUSA Pharma grew their employee count by -9% last year.

EUSA Pharma's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP Head Global FinanceReveal Email/Phone
3
Head Quality Assurance, Pharmacien ResponsableReveal Email/Phone
4
Head Franchise, Oncology, UK & IrelandReveal Email/Phone
5
Head Global Regulatory Affairs, OncologyReveal Email/Phone
6
Head PV and National Contact Person for Pharmacovigilance for the UKReveal Email/Phone
7
Head OperationsReveal Email/Phone
8
Head Legal & Compliance, AmericasReveal Email/Phone
9
Associate Director Global CMC Regulatory Affairs (biologics, orphan drugs)Reveal Email/Phone
10
Supply Chain Associate DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2860M34038%$2B$8.9B
Add Company

What Is EUSA Pharma?

EUSA Pharma is a rapidly growing specialty pharmaceutical company. We are passionate and committed to making our products globally available to enable patients to live and embrace life. Headquartered in the UK, we supply medicines and medical devices across Europe and the US through our direct sales force, and worldwide through a network of partners in more than 60 countries. We pride ourselves on living our values in everything we do - we respect, we care, we adapt, we have ambition and we deliver.

keywords:N/A

$54.2M

Total Funding

182

Number of Employees

$45.7M

Revenue (est)

-9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

EUSA Pharma News

2022-04-19 - Oral Mucositis Drugs for Cancer Therapy Market Analysis 2022 to ...

Key players – 3M Healthcare, GSK, Pfizer, Colgate-Palmolive, Norgine, Sobi, Bausch Health, EUSA Pharma, Camurus, Clinigen Group,...

2022-04-17 - Most Blood Cancer Drug Trials Are Not Randomized, Use Surrogate ...

Disclosures: Dr Goodman disclosed consulting for EUSA Pharma and Seagen. His coauthors also declared affiliations with biotech,...